ICICI Prudential Nifty Pharma Index Fund - Growth

arrow-up
NAV
₹ 16.8986 ₹ 0.11 (0.67 %)
as on 11-07-2025
Asset Size (AUM)
91.49 Cr
Launch Date
Dec 14, 2022
Investment Objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Minimum Investment 1000.0
Minimum Top-up 1000.0
Investment Returns Since Launch in Dec 14, 2022
arrow-up

22.9

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
N/A
Expense Ratio
0.98%
Volatility
N/A
Fund House
ICICI Prudential Mutual Fund
Fund Manager
Nishit Patel
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 1000.0 (plus in multiples of Rs. 1000.0)

Entry Load
Not applicable
Exit Load
Nil
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFD
Fund₹ 10772
FD₹ 10600
Performance

Scheme Performance (%)

Data as on - 11-07-2025
Created with Highcharts 4.1.4ReturnsICICI Prudential Nifty Pharma Index Fund - GrowthNifty Pharma TRIIndex FundYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesICICI Prudential Nifty Pharma Index Fund - GrowthNifty Pharma TRIIndex Fund2016201720182019202020212022202320242025-20020406080
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund120,000121,6611,6613.02
Benchmark120,000122,1812,1813.97
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
ICICI Prudential Nifty Pharma Index Fund - Growth 14-12-2022 7.72 25.6 0.0 0.0 0.0
Kotak Nifty Financial Services Ex-Bank Index Fund - Regular Plan - Growth option 14-08-2023 18.71 0.0 0.0 0.0 0.0
Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - Growth 26-04-2024 18.23 0.0 0.0 0.0 0.0
ICICI Prudential NASDAQ 100 Index Fund - Growth 01-10-2021 15.65 25.02 27.05 0.0 0.0
Motilal Oswal S&P 500 Index Fund - Regular Plan Growth 05-04-2020 14.54 20.75 19.95 17.38 0.0
Portfolio Analysis
Portfolio as on 31-05-2025
Sector Allocation
SectorAllocation (%)
Healthcare99.91
Portfolio Holdings
CompanyHoldings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-23.72
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-11.01
CIPLA LIMITED EQ NEW FV RS.2/-10.81
Dr. Reddys Laboratories Ltd10.01
LUPIN LIMITED EQ NEW F.V. RS.2/-6.2
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-4.35
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-4.21
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-3.65
ALKEM LABORATORIES LIMITED EQ3.55
LAURUS LABS LIMITED EQ NEW FV RS. 2/-3.13
ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/-3.05
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-2.88
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-2.6
ABBOTT INDIA LIMITED EQ2.08
BIOCON LIMITED EQ1.98
GLAND PHARMA LIMITED EQ NEW FV Re.1/-1.66
JB Chemicals & Pharmaceuticals Limited1.58
AJANTA PHARMA LIMITED EQ NEW FV RS. 2/-1.39
NATCO PHARMA LIMITED EQ NEW FV RS. 2/-1.04
GRANULES INDIA LIMITED EQ NEW FV RE. 1/-1.01
TREPS0.31
Net Current Assets-0.22
Sector Allocation
Created with Highcharts 4.1.4Others
Portfolio Holdings
Created with Highcharts 4.1.4SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-CIPLA LIMITED EQ NEW FV RS.2/-Dr. Reddys Laboratories LtdLUPIN LIMITED EQ NEW F.V. RS.2/-TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-ALKEM LABORATORIES LIMITED EQOthers